Innovent Biologics, Inc. (IVBXF)

Innovent Biologics Market Cap

Innovent Biologics has a market cap or net worth of $8.20 billion as of March 12, 2025. Its market cap has decreased by -1.42% in one year.

• Market Cap: 8.20B
• Enterprise Value: 7.47B
• Revenue: 1.03B
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: $5.15

Market Cap Chart

Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 8.20B, an increase of 246.89%. That is a compound annual growth rate of 21.57%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2025	8.20B	6.24%
Dec 31, 2024	7.72B	-12.83%
Dec 29, 2023	8.85B	34.32%
Dec 30, 2022	6.59B	-27.14%
Dec 31, 2021	9.05B	-39.06%
Dec 31, 2020	14.84B	244.94%